Novonesis signs deal to buy remaining stake in MicroBioGen

Reuters2026/08/10 07:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Novozymes will acquire the remaining shares of MicroBioGen, lifting its stake from 23% to full ownership.
MicroBioGen is an Australian biotech focused on yeast strains for industrial use, with a core position in bioethanol.
The deal extends a partnership dating to Novozymes’ 2013 investment, aimed at strengthening yeast and R&D capabilities.
Financial terms were not disclosed; closing is subject to customary regulatory clearances, including review by Australia’s ACCC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novozymes A/S published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novonesis signs deal to buy remaining stake in MicroBioGen

You may also like

Crypto prices